Φορτώνει......
The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial
B7x (B7-H4, B7S1, VTCN1) was discovered by us and others in 2003 as the seventh member of the B7 family. It is an inhibitory immune checkpoint with great significance to human diseases. Tissue-expressed B7x minimizes autoimmune and inflammatory responses. It is overexpressed in a broad spectrum of h...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Trends Pharmacol Sci |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6907741/ https://ncbi.nlm.nih.gov/pubmed/31677920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2019.09.008 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|